Finzati - Logo
DHR logo

Danaher Corporation

DHR • Medical - Diagnostics & Research
$207.66
▼ -3.37 (-1.60%)
Current price
EarningsLatest report: Jun 26, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$146.94B
Growth
9.5%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 14.7%Positive free cash flow · 7.44Consistent free cash flow · 5/5Manageable debt level · 0.35Healthy liquidity · 1.87
Financial data as of: Jun 26, 2026, 12:00 AM UTCLast earnings update: Jun 26, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$207.66
Change-1.60%
Shares Out707.60M
Market Cap$146.94B
Enterprise Value$169.15B
52W Range160.93 - 242.80
Beta0.83
P/E36.70
P/S5.85
P/B2.79
P/FCF26.88
EV/Sales6.74

Investment DNA

How strong this company looks for long-term investors

65
out of 100
Business Quality
Margins, moat, returns
70/100
Financial Strength
Debt, cash, stability
93/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
45/100
Why this score▼
Stable or improving margins · 14.7%Positive free cash flow · 7.44Consistent free cash flow · 5/5Manageable debt level · 0.35Healthy liquidity · 1.87Expensive earnings multiple · 44.8

Analyst view

Analyst sentiment and price target

DHR
Analyst sentiment
Based on 43 analyst votes · 2026-09-05
84/100
Bullish
Bullish
30
Hold
12
Bearish
1
Price Target
2026-07-23
Low
$195.00
Mean
$221.58
Median
$225.00
High
$249.00

Company Overview

IPO: 12/29/1978
Industry: Medical - Diagnostics & Research
P/B i: 2.79
Debt / Equity i: 0.35
Operating Margin: 20.91%
Net Margin: 14.71%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.35
Current Ratio: 1.87
Quick Ratio: 1.51
Status: Strong

Insider Transactions

Recent executive and insider activity

Zerhouni Elias A.
Transaction: 07/15/2026
SELL
Change
-3,298
Price
$71.88
Filing
07/16/2026
Type
SELL
Zerhouni Elias A.
Transaction: 07/15/2026
SELL
Change
-1,181
Price
$200.79
Filing
07/16/2026
Type
SELL
FILLER LINDA
Transaction: 07/15/2026
SELL
Change
-3,298
Price
$71.88
Filing
07/16/2026
Type
SELL